Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Feb;18(1):52-61.
doi: 10.1007/s11307-015-0870-4.

700-nm Zwitterionic Near-Infrared Fluorophores for Dual-Channel Image-Guided Surgery

Affiliations

700-nm Zwitterionic Near-Infrared Fluorophores for Dual-Channel Image-Guided Surgery

Hoon Hyun et al. Mol Imaging Biol. 2016 Feb.

Abstract

Purpose: The purpose of this study was to develop a family of 700-nm zwitterionic pentamethine indocyanine near-infrared fluorophores that would permit dual-channel image-guided surgery.

Procedures: Three complementary synthetic schemes were used to produce novel zwitterionic chemical structures. Physicochemical, optical, biodistribution, and clearance properties were compared to Cy5.5, a conventional pentamethine indocyanine now used for biomedical imaging.

Results: ZW700-1a, ZW700-1b, and ZW700-1c were synthesized, purified, and analyzed extensively in vitro and in vivo. All molecules had extinction coefficients ≥199,000 M(-1) cm(-1), emission ≥660 nm, and stability ≥99 % after 24 h in warm serum. In mice, rats, and pigs, ≥80 % of the injected dose was completely eliminated from the body via renal clearance within 4 h. Either alone or conjugated to a tumor targeting ligand, ZW700-1a permitted dual-channel, high SBR, and simultaneous imaging with 800-nm NIR fluorophores using the FLARE® imaging system.

Conclusions: Novel 700-nm zwitterionic NIR fluorophores enable dual-NIR image-guided surgery.

Keywords: Image-guided surgery; Near-infrared fluorescence; Optical imaging; Signal-to-background ratio.

PubMed Disclaimer

Conflict of interest statement

CONFLICT OF INTEREST STATEMENT

Dr. Frangioni is CEO of Curadel, LLC, a for-profit company that has licensed FLARE™ technology from the Beth Israel Deaconess Medical Center.

Figures

Figure 1
Figure 1. Synthetic schemes and 3D structures of ZW700-1 NIR fluorophores
a) Synthetic scheme for the three molecules studied. b) 3D structures and net charges of ZW700-1 and Cy5.5. Red: negative charge; blue: positive charge; gray: hydrophobic.
Figure 2
Figure 2. Live cell imaging and cytotoxicity of NIR fluorophores in C2C12 mouse myoblast cells
a) Shown are phase contrast and NIR images of each cell line tested at a concentration of 2 µM (exposure time = 200 msec). Scale bars = 100 µm. b) Cell viability was plotted 1 day post-treatment of each NIR fluorophore at a concentration of 2 µM (left) or 10 µM (right). Data are representative of N = 6 independent experiments per condition (mean ± S.D.). *P < 0.05.
Figure 3
Figure 3. In vivo clearance and elimination of ZW700-1 fluorophores in mice
a) 10 nmol of ZW700-1 NIR fluorophores were injected intravenously into 25 g CD-1 mice 4 h prior to imaging. Exposure time = 200 msec. Abbreviations used are: Bl, bladder; Du, duodenum; In, intestine; Ki, kidneys; Li, liver; Lu, lungs; Pa, pancreas; Sp, spleen. Scale bars = 1 cm. b) UPLC chromatography and ESI-TOF mass spectrometry of ZW700-1 fluorophores in mouse urine 4 h post-injection. Desalting microcolumns, packed with Poros R2 resin (Applied Biosystems, Framingham, MA), were used to remove excess salts and contaminants from urine samples. Data are representative of N = 3 independent experiments per condition.
Figure 4
Figure 4. In vivo clearance and elimination of ZW700-1 fluorophores in pigs
5 µmol of ZW700-1 NIR fluorophores were injected intravenously into 35 kg Yorkshire pigs 4 h prior to imaging. Exposure time = 200 msec. Abbreviations used are: Bl, bladder; Ki, kidneys; Li, liver; Sp, spleen, St, stomach, Ur, ureter. Scale bars = 1 cm. For blood clearance (%ID/g), blood half-life (mean ± 95% confidence intervals), and urine elimination of ZW700-1a and ICG in pig. Data are representative of N = 3 independent experiments per condition (mean ± S.D.). ***P < 0.001.
Figure 5
Figure 5. Simultaneous in vivo dual-channel NIR fluorescence imaging in the same animal
a) Renal vs. hepatobiliary clearance: 50 nmol of ZW700-1a and ICG were intravenously injected into a 250 g Sprague-Dawley rat 1 h prior to imaging (N =3). Kidneys, bladder, and ureters (arrows) were imaged using the 700 nm NIR channel (exposure time = 200 msec), while liver, duodenum, and bile duct (arrowhead) were imaged using the 800 nm (exposure time = 100 msec). Abbreviations used are: Bl, bladder; Du, duodenum; In, intestine; Ki, kidneys; Li, liver. b) Vasculature and tumor imaging: 10 nmol of BSA-ZW700-1a and 25 nmol of cRGD-ZW800-1 were injected into a 25 g xenograft tumor mouse 1 h and 4 h prior to imaging, respectively (N =3). Vasculature was imaged using the 700 nm NIR channel (exposure time = 200 msec), while integrin-αvβ3 overexpressing tumor (Tu; arrowheads) was imaged using the 800 nm channel (exposure time = 100 msec). The 700 nm and 800 nm images were pseudo-colored in red and green, respectively to generate the merged image. Scale bars = 1 cm.

References

    1. Achilefu S. The insatiable quest for near-infrared fluorescent probes for molecular imaging. Angew Chem Int Ed Engl. 2010;49:9816–9818. - PMC - PubMed
    1. Kobayashi H, Ogawa M, Alford R, et al. New strategies for fluorescent probe design in medical diagnostic imaging. Chem Rev. 2010;110:2620–2640. - PMC - PubMed
    1. Vahrmeijer AL, Hutteman M, van der Vorst JR, et al. Image-guided cancer surgery using near-infrared fluorescence. Nat Rev Clin Oncol. 2013;10:507–518. - PMC - PubMed
    1. Choi HS, Nasr K, Alyabyev S, et al. Synthesis and in vivo fate of zwitterionic near-infrared fluorophores. Angew Chem Int Ed Engl. 2011;50:6258–6263. - PMC - PubMed
    1. Choi HS, Gibbs SL, Lee JH, et al. Targeted zwitterionic near-infrared fluorophores for improved optical imaging. Nat Biotechnol. 2013;31:148–153. - PMC - PubMed

Publication types

Substances